TKL secures first NIH R01 grant!

We're thrilled to announce that TKL has been awarded our first NIH R01 grant! This five-year project aims to develop a platform for drug susceptibility testing in tuberculosis. By leveraging novel probes based on the sugar trehalose, our approach will enable phenotypic, drug-agnostic, rapid, and low-complexity testing, paving the way for improved treatment strategies. Congratulations to everyone in the lab for this incredible achievement!